Abstract
Background
Methods
Results
Conclusion
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of MedicineReferences
- Impact of vena cava filters on in-hospital case fatality rate from pulmonary embolism.Am J Med. 2012; 125: 478-484
- Antithrombotic therapy for VTE disease: antithrombotic therapy for prevention of thrombosis, 9th ed. American College of Chest Physicians Evidence-Based Guidelines.Chest. 2012; 141: e419S-e494S
- Thrombosis and cancer.Semin Oncol. 2000; 27: 362-374
- Cancer and thrombosis.Haemostasis. 1994; 24: 128-131
- Incidence of venous thromboembolism in patients hospitalized with cancer.Am J Med. 2006; 119: 60-68
HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP) 1998-2009. Rockville, MD: Agency for Healthcare Research and Quality. Available at: www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed January 20, 2013.
- Case fatality rate with pulmonary embolectomy for acute pulmonary embolism.Am J Med. 2012; 125: 471-477
- Inferior vena caval filters: review of a 26-year single-center clinical experience.Radiology. 2000; 216: 54-66
- The role of vena caval interruption in patients with venous thromboembolism.Prog Cardiovasc Dis. 1994; 37: 25-37
- Inferior vena cava filters in the management of cancer-associated venous thromboembolism: a systematic review.Oncol Rev. 2010; 4: 147-157
- Treatment of patients with venous thromboembolism and malignant disease: should vena cava filter placement be routine?.J Vasc Surg. 1998; 28: 800-807
- Inferior vena cava filter placement in late-stage cancer.Vasc Endovasc Surg. 2006; 40: 287-294
- Outcome and complications of retrievable inferior vena cava filters.Am J Cardiol. 2004; 94: 1090-1093
- Outcomes with retrievable inferior vena cava filters.J Invasive Cardiol. 2010; 22: 235-239
FDA Advisory, August 09, 2010. Removing retrievable inferior vena cava filters: initial communication. Available at: http://www.fda.gov/MedicalDevices/Safety/AltersandNotices/ucm221676.htm. Accessed January 25, 2013.
- Vena cava filters in hospitalized patients with chronic obstructive pulmonary disease and pulmonary embolism.Thromb Haemost. 2013; 109: 897-900
- A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group.N Engl J Med. 1998; 338: 409-415
- Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study.Circulation. 2005; 112: 416-422
- Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution.J Clin Epidemiol. 2010; 63: 223-228
- The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly.Arch Intern Med. 1994; 154: 861-866
Article info
Footnotes
Funding: None.
Conflict of Interest: None.
Authorship: All authors had access to the data and a role in writing the manuscript.